IRIDIS

Iridis

Therapeutic devices’ development for diabetes related pathologies’ treatment

Structure

DURATION

2 YEARS

BUDGET

€ 2.104.067,53

FUNDING

€ 972.034,81

Project mission

IRIDIS aims to develop a centre of expertise through the implementation of a cooperative network made up of private and public institutions, participating in acquiring the best scientific know-how and technical skills concerning the study, diagnosis and treatment of type B diabetes pathologies. The research focuses on the new drugs’ breakthrough regarding the cure and therapy of diabetic ulcers, neuropathic pain, glycaemia adjustment and diabetic retinopathy. The foreseen output implies also the development of a experimental platform for early indicators of disease’s severity.

Communications materials

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem laudantium in adipisci ipsa optio quas id excepturi non, eos cupiditate, necessitatibus sapiente illo error. Vero adipisci quidem aut itaque labore.

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem laudantium in adipisci ipsa optio quas id excepturi non, eos cupiditate, necessitatibus sapiente illo error. Vero adipisci quidem aut itaque labore.

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem laudantium in adipisci ipsa optio quas id excepturi non, eos cupiditate, necessitatibus sapiente illo error. Vero adipisci quidem aut itaque labore.

Project Partners

Consiglio Nazionale delle Ricerche
ICRM-CNR
Naicons
Address

Legal and administrative residence
Via Gaudenzio Fantoli 16/15
20138 Milano